GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the PDZ tandem of human syntenin in complex with tnefaf peptide

Analyse Crystal structure of the PDZ tandem of human syntenin in complex with tnefaf… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1W9Q
Type
protein
Length
331 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Syntenin 1; Tnefaf peptide
UniProt
O00560
Ligands
BEZ
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 2 distinct chains · 17% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSyntenin 1protein16317% helix, 39% strandO00560
STnefaf peptideprotein50% helix, 40% strand—

Ligands and binding sites

  • BEZ · Benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.300.7413empty

Interfaces

2 interfaces between chains.

  • A–B · 1060 Ų buried · 14 hydrogen bonds · protein-protein
  • B–S · 431 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 1W9Q · Crystal structure of the PDZ tandem of human syntenin in complex with TNEFAF peptide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.